Oncomine Comprehensive Plus Panel: Advanced Cancer Genetic Testing
Comprehensive Introduction to Advanced Cancer Genomics
The Oncomine Comprehensive Plus Panel represents the cutting edge of cancer genetic testing, utilizing next-generation sequencing (NGS) technology to provide unprecedented insights into your cancer’s molecular profile. This comprehensive genomic analysis examines over 500 cancer-related genes simultaneously, offering a complete picture of the genetic alterations driving tumor growth and progression. Developed by leading genetic researchers, this panel has revolutionized precision oncology by enabling truly personalized treatment approaches based on individual genetic makeup.
Cancer treatment has evolved significantly from the one-size-fits-all approach of traditional chemotherapy. The Oncomine Comprehensive Plus Panel empowers both patients and healthcare providers with detailed molecular information that can guide treatment selection, predict treatment response, and identify potential resistance mechanisms. By understanding the specific genetic drivers of your cancer, oncologists can recommend targeted therapies that are more likely to be effective while minimizing unnecessary side effects from treatments that may not work for your specific cancer type.
What the Oncomine Comprehensive Plus Panel Detects
This advanced genetic panel provides comprehensive analysis across multiple genetic alteration types:
Comprehensive Genetic Mutation Analysis
- Single Nucleotide Variants (SNVs): Identifies point mutations in key cancer driver genes
- Insertions and Deletions (Indels): Detects small insertions and deletions that can disrupt gene function
- Gene Fusions: Identifies fusion events between different genes that create novel oncoproteins
- Copy Number Variations (CNVs): Detects gene amplifications and deletions that affect cancer progression
- Biomarker Analysis: Evaluates predictive and prognostic biomarkers for targeted therapy selection
Key Cancer Pathways Covered
The panel comprehensively analyzes genes involved in critical cancer pathways including:
- Cell cycle regulation and DNA damage repair pathways
- Growth factor signaling and receptor tyrosine kinases
- Apoptosis and programmed cell death mechanisms
- Angiogenesis and tumor microenvironment interactions
- Immune checkpoint and immunotherapy response markers
Who Should Consider the Oncomine Comprehensive Plus Panel
This comprehensive genetic testing is particularly valuable for patients experiencing:
Clinical Indications and Symptoms
- Patients with advanced or metastatic cancer seeking targeted therapy options
- Individuals with rare or difficult-to-treat cancer types
- Patients who have failed standard treatment regimens
- Those with family history of cancer or suspected hereditary cancer syndromes
- Individuals seeking second opinions or considering clinical trial participation
- Patients with recurrent cancer requiring new treatment strategies
Specific Cancer Types Benefiting from Testing
- Lung cancer, breast cancer, colorectal cancer, and prostate cancer
- Melanoma, ovarian cancer, and pancreatic cancer
- Brain tumors, leukemia, and lymphoma
- Rare sarcomas and neuroendocrine tumors
Significant Benefits of Comprehensive Genetic Testing
Choosing the Oncomine Comprehensive Plus Panel offers numerous advantages for cancer patients:
Personalized Treatment Advantages
- Targeted Therapy Selection: Identifies specific genetic alterations that can be targeted with precision medicines
- Clinical Trial Matching: Helps identify appropriate clinical trials based on genetic profile
- Treatment Response Prediction: Provides insights into likely treatment effectiveness
- Resistance Mechanism Identification: Detects genetic changes that may cause treatment resistance
Clinical Management Benefits
- Improved Treatment Outcomes: Enables selection of therapies with higher likelihood of success
- Reduced Side Effects: Helps avoid ineffective treatments and unnecessary toxicity
- Comprehensive Molecular Profiling: Single test provides extensive genetic information
- Family Risk Assessment: Identifies potential hereditary cancer risks for family members
Understanding Your Test Results
Interpreting your Oncomine Comprehensive Plus Panel results requires professional medical guidance:
Result Interpretation Framework
- Actionable Mutations: Genetic alterations with approved targeted therapies available
- Investigational Targets: Mutations with potential clinical trial options
- Prognostic Markers: Genetic changes that provide information about disease course
- Resistance Markers: Alterations that may indicate reduced treatment effectiveness
Next Steps After Testing
Your oncology team will review the comprehensive report and discuss:
- Available targeted therapy options matching your genetic profile
- Potential clinical trial opportunities based on specific mutations
- Treatment sequencing strategies to maximize effectiveness
- Monitoring plans to track treatment response and potential resistance
Test Pricing and Booking Information
| Test Description | Price (USD) |
|---|---|
| Oncomine Comprehensive Plus Panel | Regular Price: $6,500 USD |
| Special Discount Price | $4,876 USD |
Test Specifications
- Turnaround Time: 2-3 weeks from sample receipt
- Sample Type: Tumor tissue (paraffin embedded tissue blocks)
- Technology: Next-generation sequencing (NGS)
- Prescription Required: Doctor’s prescription needed (not applicable for surgery, pregnancy, or international travel planning)
Nationwide Accessibility and Booking
We have diagnostic centers conveniently located across major cities throughout the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.
Easy Test Booking Process
Schedule your Oncomine Comprehensive Plus Panel today by calling our dedicated genetics specialists at +1(267) 388-9828. Our team will guide you through the pre-test requirements, sample collection process, and answer any questions about this comprehensive cancer genetic analysis. Take the first step toward personalized cancer treatment based on your unique genetic profile.
Call now to book your comprehensive cancer genetic testing and unlock personalized treatment options tailored to your specific cancer genetics.
